Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

23 Jul 2015 07:00

RNS Number : 8211T
Biome Technologies PLC
23 July 2015
 



 

23 July 2015

Biome Technologies plc

 

 ("Biome", "the Company" or "the Group")

 

Trading Update

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today publishes its trading update for the six-month period ended 30 June 2015. The interim results are expected to be announced on 2 September 2015.

 

Trading Update

Total Group Revenues for the first half were £2.1m (H1 2014 £2.3m), including revenues for the second quarter of 2015 of £0.9m (Q1 2015: £1.1m). The turnover for the second quarter maintains the significant progress made in the first quarter of 2015 albeit partly constrained by later phasing of shipments from the RF Technologies Division.

 

The Group's cash position at 30 June 2015 was £1.8m (31 March 2015: £2.3m), reflecting both an increase in working capital ahead of expected shipments in Q3, new product development costs and trading performance.

 

 

Bioplastics Division

Revenues generated by the Bioplastics Division in the first half of 2015 totalled £1.0m (H1 2014 £1.1m).

 

Order levels of the division's commercialised products have recovered substantially in the first half of this year, driven by an improvement in the US market which has seen demand return to levels broadly similar to those seen in the first half of 2014.

 

Additionally, the second half of this year should be favourably impacted by a new product line we have developed reaching its commercialisation phase; initial order rates are already encouraging.

 

Three grant supported research collaborations focused on bio-based materials, highlighted in previous statements, commenced in the first half.

 

Stanelco RF Technologies Division

Revenues for this division in the first half of 2015 were £1.0m (2014: £1.2m). A robust and significant order book for the remainder of the year should see the turnover weighting for the second half substantially above that of the first half of 2015.

 

The recently announced signing of a £1.1m contract to supply optic fibre furnaces in the second half of the year will add considerably to the division's existing pipeline. Additional enquiries indicate that the optic fibre furnace market is more buoyant than it has been for some time, with customers seeking upgrades as well as additional capacity. The contract with a customer from a regulated industry is progressing on time and to plan with the delivery of the first system anticipated in the second half.

 

Group Outlook

Group revenues at the mid-year point are in line with the Board's expectations with a reduced operating loss during the period relative to those expectations. The Board is confident that momentum in revenue growth should accelerate in the second half of the year.

 

-Ends-

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Chris Crawford/Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

FTI Consulting

Oliver Winters

www.fticonsulting.com

Tel: +44 (0) 20 3727 1535

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPKBDKABKDKOB
Date   Source Headline
21st Mar 20257:00 amRNSCancellation- Biome Technologies PLC
13th Mar 202512:22 pmRNSResult of GM & update on Cancellation
21st Feb 20257:00 amRNSProposed Cancellation & Notice of GM
18th Dec 20247:00 amRNSSecured Funding Facility
4th Dec 20247:00 amRNSTrading Update and Board Change
13th Nov 20247:00 amRNSTrading Update
25th Oct 20247:00 amRNSAppointment of Non-Executive Director
30th Sep 20245:00 pmRNSTotal Voting Rights
30th Sep 202411:08 amRNSContract win for Stanelco RF Division
20th Sep 20247:00 amRNSInterim Results
13th Sep 202410:58 amRNSHolding(s) in Company
12th Sep 202411:43 amRNSHolding(s) in Company
11th Sep 20243:01 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHolding(s) in Company
9th Sep 20244:51 pmRNSHolding(s) in Company
4th Sep 20242:39 pmRNSResult of General Meeting and TVR
30th Aug 20245:00 pmRNSTotal Voting Rights
23rd Aug 20242:42 pmRNSHolding(s) in Company
22nd Aug 202411:00 amRNSHolding(s) in Company
22nd Aug 20247:00 amRNSResult of Retail Offer, Director dealing and TVR
21st Aug 20244:12 pmRNSHolding(s) in Company
21st Aug 20241:41 pmRNSHolding(s) in Company
16th Aug 20247:05 amRNSRetail offer to raise up to £80,000
16th Aug 20247:01 amRNSProposed Fundraise and other matters
16th Aug 20247:00 amRNSTrading update
10th Jul 20247:00 amRNSDirectorate Change
8th Jul 20247:00 amRNSTrading update
12th Jun 20247:00 amRNSGrant of Options
29th May 202410:57 amRNSResult of AGM, Interim CFO and Directorate Change
22nd May 20242:27 pmRNSContract win for Stanelco RF Division
15th May 20247:00 amRNSNotice of AGM and 2023 Annual Report
29th Apr 20247:01 amRNSTrading Update
29th Apr 20247:00 amRNSFinal Results 2023
15th Mar 20247:00 amRNSContract win for Stanelco RF Division
11th Mar 20241:59 pmRNSIssue of Convertible Loan Notes, PDMR Notification
15th Feb 20242:54 pmRNSContract win for RF Division
6th Feb 20247:00 amRNSTrading Update
13th Nov 20237:00 amRNSTrading Update
10th Oct 20234:32 pmRNSGrant of Options
27th Sep 20237:00 amRNSInterim Results
26th Jul 20237:00 amRNSTrading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20237:00 amRNSContract win for Stanelco RF Division
31st May 20237:00 amRNSIssue of Equity, Director/PDMR Shareholding & TVR
25th May 20232:57 pmRNSAppointment of Non-Executive Director
25th May 202312:45 pmRNSResult of AGM
2nd May 20231:05 pmRNSDirector/PDMR Shareholding
27th Apr 20237:00 amRNSNotice of AGM and 2022 Annual Report
26th Apr 20237:01 amRNSTrading Update
26th Apr 20237:00 amRNSFinal Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.